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BACKGROUND. Cutaneous hyperpigmentation is one of the
most cosmetically disturbing sequel of drug-induced toxic ep-
idermal necrolysis. Intense pulsed light is a promising tool for
treating some melanocytic lesions.
OBJECTIVE. The objective was to assess the effect of intense
pulsed light in treating post-toxic epidermal necrolysis facial
hypermelanosis.
METHODS. Two Caucasian men aged 35 and 50 years presented
with long-standing (32 and 39 years) severe hypermelanosis of
the face after sulfonamide-induced toxic epidermal necrolysis.
They were treated by intense pulsed light. Cutoff filters of 550,
590, and 615 nm were employed for five intense pulsed light
sessions at 4-week intervals. The treatment was characterized
by energy fluence of 25 to 32 J/cm2, pulse width of 2.2 to 3.2
ms, and double- to triple-pulse mode respecting a 30-ms delay.
Before intense pulsed light treatment, and 2 months after the
fifth intense pulsed light session, clinical photographs and skin
biopsies were performed in combination with quantitative nar-
row-band remittance spectrophotometry of melanin pigmenta-
tion. Patients were clinically followed-up for 8 months after the
end of the treatment.
RESULTS. In both patients, clinical, histologic, and spectropho-
tometric assessments showed an average of 80% decrease in the
hypermelanosis. No clinical recurrence of the hypermelanosis
developed during the 8-month follow-up after intense pulsed
light treatment. No major persistent side effects were experi-
enced, especially hypopigmentation.
CONCLUSION. Intense pulsed light appears to be effective and
safe for treating post-toxic epidermal necrolysis hypermelanosis
in Caucasian patients.
PHILIPPE PAQUET, MD, PHD, AND GE´RALD E. PIE´RARD, MD, PHD HAVE INDICATED NO SIGNIFICANT INTEREST
WITH COMMERCIAL SUPPORTERS.
DRUG-INDUCED TOXIC epidermal necrolysis is a
rare, potentially lethal disease characterized by sudden
epidermal necrosis. The only recognized cause of the
disease is an adverse reaction to drugs, especially
sulfonamides, phenytoin, nonsteroidal anti-inflamma-
tory drugs, and allopurinol.1 The toxic epidermal ne-
crolysis–induced death rate reaches approximately
30%.1 Long-term sequelae in the survivors remain
frequent.1 Pulmonary, myocardial, osseous and gas-
trointestinal complications have also been described.1
The most common long-term consequences, however,
affect the eyes, skin, oral and genital mucosae, and
nails.2–4 Cutaneous sequelae include keloidal scars,
alopecia, speckled eruptive melanocytic nevi, and
hyper- or hypomelanosis.3,4
We report two adult patients presenting with long-
standing hypermelanosis of the face following toxic
epidermal necrolysis that developed during childhood.
The hyperpigmentation was treated successfully by
intense pulsed light. To the best of our knowledge,
these cases are the first descriptions of post-toxic
epidermal necrolysis hyperpigmentation treated by
intense pulsed light. We also briefly discuss the
pathogenesis of post-toxic epidermal necrolysis
hypermelanosis.
Case Report
Two phototype II Caucasian men, aged 35 and 50
years, suffered from toxic epidermal necrolysis at the
age of 3 and 11 years, respectively. The clinical pres-
entation was similar for the two patients, including
epidermal sloughing over 50% of the body surface,
and severe involvement of the face, eyes, and mucous
membranes. Trimethoprim-sulfamethoxazole of the
sulfonamide-class antibiotic was identified as the cul-
prit drug in both cases. Cutaneous biopsies taken at
the onset of the disease confirmed the diagnosis of
toxic epidermal necrolysis. After the early recovery
phase of the disease, facial skin showed a scar texture
with a persistent diffuse and severe hypermelanosis,
particularly prominent on the cheeks. By contrast, the
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other parts of the body surface fully recovered without
any pigmentary change.
An intense pulsed light device (MultilightT, ESC
Medical Systems Ltd, Yokneam, Israel) was used to
treat the hypermelanosis in a five-session procedure
with respective intervals of 4 to 6 weeks. Cutoff filters
of 550, 590, and 615 nm were used. To deal with the
superficial pigmentation, treatments started using the
550-nm cutoff filter, a single pulse mode at 25 J/cm2
fluence, and a pulse width of 3.6 ms. To tackle deeper
pigmentation when previous attempts with the shorter
cutoff filter failed to clear the melanoderma, the cutoff
filter was switched to 590 or 615 nm A double- or
triple-pulse mode combined with a pulse width of
3.2 or 2.2 ms, a 30-ms delay, and a fluence of 25 to 30
and 26 to 32 J/cm2 were employed using 590- and
615-filters, respectively. The two cheeks were entirely
treated with a 2.8  0.8-cm spot size, representing
25 to 35 pulses by session. The intense pulsed light
spots overlapped by about 10%. Before treatment,
skin cooling was obtained using cold packs for 1 min.
In addition, a 2-mm-thick coating with a chilled
colorless gel was applied to the treatment area to
protect the epidermis from thermal injury and to help
deliver the light uniformly at the skin surface. No
local anesthesia was used. Patients were advised to
apply a corticosteroid and antiseptic combination
cream (Fucicort, Leo) twice daily for 7 days. In
the period covering 2 months before treatment,
the whole treatment phase, and 2 months after treat-
ment, the patients were advised to avoid sun exposure
and they regularly applied a sun-protective (SPF 60)
product.
The treatment response was assessed by comparing
pre- and posttreatment clinical photographs, cutane-
ous biopsies, and data from remittance spectropho-
tometry. Posttreatment evaluations were performed 2
and 8 months after the fifth intense pulsed light ses-
sion. This period covered the summer season. Pre- and
posttreatment biopsy specimens were taken close to
each other. Sections were stained with Fontana-Mas-
son silver stain to reveal melanin. A narrow-band
spectrophotometer (Mexameter, C1K Electronic, Co-
logne, France) was used according to the EEMCO
recommendations.5 The melanin index was measured
on two different sites of the cheeks. Melanin index
assessments were precisely performed each time on
the same sites. To avoid any influence of skin color
variation due to skin tanning, drug and alcohol intake,
physical exercise, and environmental temperature,
results were expressed as a differential melanin index
(DM) between each of the melanin index values
obtained at the target sites and another selected area
of normal looking skin on the anterior part of
the neck. M and DM values were expressed in arbi-
trary units. The posttreatment DM value was also
calculated as a percentage relative to the pretreatment
value.
Results
Deep purpuric spots developed rapidly after each in-
tense pulsed light session. In some areas, especially at
the beginning of the treatment, the patients developed
blisters and crusts that resolved within 1 week leaving
some discrete and transient depressed scars. After 3
months, the scars had cleared without leaving perma-
nent marks.
The clinical assessment of treatment efficacy was
supported by comparing the photographs. Overall, the
two patients showed a marked clinical improvement of
melanization after the fifth intense pulsed light session
(Figure 1). The treatment did not induce any obvious
hyper- or hypopigmentation. Eight months after the
last intense pulsed light session, hypermelanosis did
not recur even following summer.
The spectrophotometer assessments showed a sharp
decrease in DM (range,  17% to  117%; mean,
 84%) at completion of the treatment in both pa-
tients (Table 1). In each case, the initial histologic ex-
amination revealed a discrete superficial perivascular
lymphoid infiltrate. The melanin overload in the deep-
est layers of the epidermis was accompanied by few
melanophages in the superficial dermis. The Fontana-
Masson stain was strongly positive. After intense
pulsed light treatment, a marked decrease of the in-
traepidermal melanin load was evidenced, but the re-
duction in dermal melanophages was less obvious
(Figure 2).
Figure 1. Post-toxic epidermal necrolysis facial hypermelanosis in Pa-
tient 2 before intense pulsed light treatment (A) and after five intense
pulsed light sessions (B).
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Discussion
Changes in skin pigmentation including hypo- and
hypermelanosis are among the most common disturb-
ing cutaneous sequelae of toxic epidermal ne-
crolysis.3,4 The modifications in the melanocyte
function are mainly seen on sun-exposed skin, al-
though actinic exposure does not seem mandatory for
their development.4
The precise pathogenesis of post-toxic epidermal
necrolysis hyperpigmentation is still obscure. In many
inflammatory diseases, epidermal melanocytes increase
in number, size, dendricity, and melanin production.
Arachidonic acid metabolites (prostaglandin E2,
thromboxane B2, leukotrienes C and D4) and hista-
mine, which are increased in amount in inflammatory
conditions, are thought to play a key role in the in-
duction of postinflammatory hypermelanosis.6,7 The
vasoconstriction peptide endothelin-1 is also a strong
keratinocyte-derived mitogen and melanogen for hu-
man melanocytes.8 Endothelin-1 secretion is stimulat-
ed by tumor necrosis factor-a, which is one of the main
cytokines involved in toxic epidermal necrolysis patho-
genesis.8 Nitric oxide might also be involved in the
process.9 Indeed, any nitric oxide excess induces ker-
atinocyte apoptosis and boosts melanocyte activity.
A direct effect of drug metabolites on epidermal
melanocytes may also be involved in the increased
melanin production. Indeed, contact between unirra-
diated melanocytes in culture and DNA-damaging
agents or thymine dinucleotides, the by-products of
DNA excision repair, is sufficient to increase the mel-
anin content and up regulate tyrosinase gene expres-
sion.10 In addition, tyrosinase expression may be up
regulated by removal of a repressor gene given the ty-
rosinase is under negative control in melanocytes.10
In our patients, the long-standing hypermelanosis
resulted from toxic epidermal necrolysis developed
during childhood and was exclusively located on the
face. It should be noted that in children aged between
1 and 15 years, the number of active melanocytes is
higher than in older subjects. The number of melano-
cytes also varies according to the region of the body,
the cheeks exhibiting one of the highest densities.11
The persistence of hypermelanosis on sun-exposed
skin in our patients suggests a ultraviolet-sustained
pathomechanism. Moreover, the sulfonamides which
are thought to be responsible for the presently reported
toxic epidermal necrolysis cases are photosensitizing
drugs.12 The mechanisms involved in ultraviolet-
induced hypermelanosis include melanocyte DNA
damage and/or repair, keratinocyte-derived hyperpro-
duction of the melanogenic factor endothelin-1, or the
destruction of tyrosinase gene repressor protein PRP
(photolyase regulatory protein).10
Dermal postinflammatory hypermelanosis results
from melanin incontinence from the epidermis.
Melanosomes are captured by dermal macrophages
and dendrocytes.12 Among them, Factor XIIIa1 den-
drocytes, whose population is particularly abundant in
Table 1. Spectrophotometry Assessments of the Differential Melanin Index between the Hypermelanotic Cheeks and the
Normal Looking Neck, Before and After Five Intense Pulsed Light Treatments










External cheek 658 325 333 ( 51%) 815 174 641 (79%)
Internal cheek 506 422 84 ( 17%) 1004 169 1173 (117%)
Patient 2
External cheek 715 –6 721 ( 101%) 956  46 1002 (104%)
Internal cheek 1043 –146 1189 ( 114%) 793 90 703 (89%)
Figure2. Fontana-Masson stain of cutaneous biopsies in Patient 2
before (a) and after five intense pulsed light sessions (b). Melanin
deposits appear in black.
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toxic epidermal necrolysis skin, have been shown to be
able to store the released melanin products.13
Different kinds of lasers (Q-switched ruby, alex-
andrite, or Nd-Yag)14–19 and intense pulsed light20–26
have been reported to be effective in treating some
pigmented lesions, especially postinflammatory hyper-
pigmentation. There is, however, no information about
the efficacy of intense pulsed light in treating post-
toxic epidermal necrolysis hypermelanosis. The mech-
anism of action of these methods relies on the selective
photothermolysis of pigmented cells. In contrast to
lasers, intense pulsed light system offers the advantage
of adjusting pulse width and wavelength according to
the skin type and depth of pigment deposits in the
skin.20–26 In our patients, the melanin overload was
mostly located in the epidermis. Thus, short wave-
lengths (cutoff filter of 550 and 590 nm) were used
preferentially. Clinical, histologic, and spectrophoto-
metric assessments showed a prominent bleaching ef-
fect after five intense pulsed light sessions. This looks
similar to the results obtained in treating postburn
hyperpigmentation by intense pulsed light.26 There
were no significant side effects, especially hypopigmen-
tation. The long-term beneficial response of the treated
area after sun exposure is difficult to predict because a
reactivation of excessive melanization cannot be ruled
out. Thus, the patients were advised to use lifetime
potent sun-protective products during sunny days.
In conclusion, toxic epidermal necrolysis can be
followed by persistent postinflammatory hype-
rmelanosis especially on sun-exposed skin. Intense
pulsed light appears to be a promising treatment for
post-toxic epidermal necrolysis epidermal hyperpig-
mentation, with the possibility to precisely adjust the
beam depth penetration according to the site of mel-
anin deposits in the skin.
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